# Pain Outcomes Following Intralesional Corticosteroid Injections

> **NCT03630198** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 31 (actual)

## Conditions studied

- Keloid
- Alopecia Areata
- Acne
- Hypertrophic Scar
- Epidermal Inclusion Cyst
- Frontal Fibrosing Alopecia
- Lichen Plano-Pilaris
- Keratoacanthoma
- Plaque Psoriasis
- Lichen Simplex Chronicus
- Prurigo Nodularis
- Nummular Eczema
- Granuloma Annulare
- Morphea
- Lichen Planus

## Interventions

- **DRUG:** Corticosteroid with lidocaine
- **DRUG:** Corticosteroid with normal saline

## Key facts

- **NCT ID:** NCT03630198
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03630198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03630198, "Pain Outcomes Following Intralesional Corticosteroid Injections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03630198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*